Effect of caudal volume injection on optic nerve sheath diameter

Effect of caudal volume injecton on optic nerve sheath diameter in pateints with failed back surgery syndrome

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20240609062049N1

Enrollment

Registered

2024-09-28

Start date

2024-07-05

Completion date

Unknown

Last updated

2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Optic nerve sheath diameter.

Interventions

Intervention group: 30 ml of solution containing 1500 units of hyaluronidase made by WOCKHARDT.UK in a volume of 10 ml within 2 minutes, 10 ml of rovacaine 0.2% made by Varian pharmed along with 40 mg

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients aged 18 to 60 years Suffering from failed back surgery syndrome Candidate for epidural adhesion removal by caudal epidural injection

Exclusion criteria

Exclusion criteria: coagulation disorders occupational brain lesions lncreased intracranial pressure infection of sacrum area systemic infections optic nerve diseases cauda equina syndrome cerbrovascular diseases uncontrolled arterial hypertension ischemic heart disease and or cardiac arrythmias

Design outcomes

Primary

Measure	Time frame
Optic nerve sheath diameter. Timepoint: Before intervention, immediately,10,20,40 minutes after intervention. Method of measurement: ultrasonography.;Optic nerve sheath diameter. Timepoint: pervious , ultimate , 10 ,20 and 40 minutes after caudal iniection. Method of measurement: ultrasonography.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSayed mohammad reza razavizadeh

Shahid Beheshti University of Medical Sciences

mr_razavi48@yahoo.com+98 21 7343 3000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026